BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 23238124)

  • 1. Osteocyte apoptosis.
    Jilka RL; Noble B; Weinstein RS
    Bone; 2013 Jun; 54(2):264-71. PubMed ID: 23238124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations.
    Kennedy OD; Herman BC; Laudier DM; Majeska RJ; Sun HB; Schaffler MB
    Bone; 2012 May; 50(5):1115-22. PubMed ID: 22342796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Osteocytes in Age-Related Bone Loss.
    Jilka RL; O'Brien CA
    Curr Osteoporos Rep; 2016 Feb; 14(1):16-25. PubMed ID: 26909563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic Osteocytes Induce RANKL Production in Bystanders via Purinergic Signaling and Activation of Pannexin Channels.
    McCutcheon S; Majeska RJ; Spray DC; Schaffler MB; Vazquez M
    J Bone Miner Res; 2020 May; 35(5):966-977. PubMed ID: 31910292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocyte apoptosis is required for production of osteoclastogenic signals following bone fatigue in vivo.
    Kennedy OD; Laudier DM; Majeska RJ; Sun HB; Schaffler MB
    Bone; 2014 Jul; 64():132-7. PubMed ID: 24709687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocyte-Mediated Translation of Mechanical Stimuli to Cellular Signaling and Its Role in Bone and Non-bone-Related Clinical Complications.
    Yan Y; Wang L; Ge L; Pathak JL
    Curr Osteoporos Rep; 2020 Feb; 18(1):67-80. PubMed ID: 31953640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic osteocytes and the control of targeted bone resorption.
    Plotkin LI
    Curr Osteoporos Rep; 2014 Mar; 12(1):121-6. PubMed ID: 24470254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocyte regulation of bone mineral: a little give and take.
    Atkins GJ; Findlay DM
    Osteoporos Int; 2012 Aug; 23(8):2067-79. PubMed ID: 22302104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone.
    Noble BS; Peet N; Stevens HY; Brabbs A; Mosley JR; Reilly GC; Reeve J; Skerry TM; Lanyon LE
    Am J Physiol Cell Physiol; 2003 Apr; 284(4):C934-43. PubMed ID: 12477665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.
    Aguirre JI; Plotkin LI; Stewart SA; Weinstein RS; Parfitt AM; Manolagas SC; Bellido T
    J Bone Miner Res; 2006 Apr; 21(4):605-15. PubMed ID: 16598381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the role of osteocytes in the initiation of targeted remodeling.
    Heino TJ; Kurata K; Higaki H; Väänänen HK
    Technol Health Care; 2009; 17(1):49-56. PubMed ID: 19478405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice.
    Weinstein RS; O'Brien CA; Almeida M; Zhao H; Roberson PK; Jilka RL; Manolagas SC
    Endocrinology; 2011 Sep; 152(9):3323-31. PubMed ID: 21771887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases.
    Pathak JL; Bravenboer N; Klein-Nulend J
    Front Endocrinol (Lausanne); 2020; 11():405. PubMed ID: 32733380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation?
    Verborgt O; Tatton NA; Majeska RJ; Schaffler MB
    J Bone Miner Res; 2002 May; 17(5):907-14. PubMed ID: 12009022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte.
    Wang T; Yu X; He C
    Curr Drug Targets; 2019; 20(1):1-15. PubMed ID: 29618305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
    Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
    PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of osteocytes in multiple myeloma bone disease.
    Delgado-Calle J; Bellido T; Roodman GD
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):407-13. PubMed ID: 25289928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion.
    Pesce Viglietti AI; Arriola Benitez PC; Gentilini MV; Velásquez LN; Fossati CA; Giambartolomei GH; Delpino MV
    Infect Immun; 2016 Jan; 84(1):11-20. PubMed ID: 26459511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.